Results 251 to 260 of about 152,806 (342)
Biphasic Kinetics of IGF-I and IGFBP-3 in Response to Military Field Training in Brazilian Air Force Recruits. [PDF]
Talarico Neto T+5 more
europepmc +1 more source
It Takes Two to Tango: IGF-I and TSH Receptors in Thyroid Eye Disease.
Girnita L, Smith TJ, Janssen JAMJL.
europepmc +1 more source
Patterns of Teprotumumab‐Induced Hearing Dysfunction: A Systematic Review
Abstract Objective Hearing loss has been reported after administration of the monoclonal antibody teprotumumab. The purpose of this study was to review available evidence regarding the patterns of teprotumumab‐related ototoxicity. Data Sources PubMed, EMBASE, and Cochrane Library.
Kevin Wong+8 more
wiley +1 more source
Association of Whole Blood Amino Acid and Acylcarnitine Metabolome with Anthropometry and IGF-I Serum Levels in Healthy Children and Adolescents in Germany. [PDF]
Jensch R+6 more
europepmc +1 more source
Advances in Molecularly Imprinted Polymers for Bone Biomarker Detection and Therapeutic Applications
This review highlights the emerging applications of molecularly imprinted polymers (MIPs) in bone regeneration and diagnosis. MIPs facilitate osteogenic treatments by guiding stem cell differentiation and delivering bioactive molecules and enable precise detection of bone turnover biomarkers via MIP‐based sensors, offering promising strategies for next‐
Ren Yang+8 more
wiley +1 more source
Normal or improved cardiovascular risk factors in IGF-I-deficient adults with growth hormone receptor deficiency. [PDF]
Guevara-Aguirre J+10 more
europepmc +1 more source
Secretome Profiling in Axon Regeneration: Emerging Techniques and Therapeutic Translation
ABSTRACT The secretome refers to the in vivo ensemble of molecular entities that are found in interstitial spaces. It is then the mere secreted products of the cells, as all biomolecules in the interstitial cellular spaces also undergo modifications. The fractionated secretome may hold potential as a cell‐free therapy option due to its role in tissue ...
Maria D. Cabrera+3 more
wiley +1 more source